Group VIA phospholipase A2 in both host and tumor cells is involved in ovarian cancer development.
about
Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapyiPLA2β overexpression in smooth muscle exacerbates angiotensin II-induced hypertension and vascular remodeling.Elevated phospholipase A2 activities in plasma samples from multiple cancers.Platelet-activating factor and metastasis: calcium-independent phospholipase A2β deficiency protects against breast cancer metastasis to the lung.Combination therapy of an inhibitor of group VIA phospholipase A2 with paclitaxel is highly effective in blocking ovarian cancer developmentAnalysis of two major intracellular phospholipases A(2) (PLA(2)) in mast cells reveals crucial contribution of cytosolic PLA(2)α, not Ca(2+)-independent PLA(2)β, to lipid mobilization in proximal mast cells and distal fibroblasts.Calcium-independent phospholipases A2 and their roles in biological processes and diseases.Elevated and secreted phospholipase A₂ activities as new potential therapeutic targets in human epithelial ovarian cancer.The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells.Mechanism-based inhibition of iPLA2β demonstrates a highly reactive cysteine residue (C651) that interacts with the active site: mass spectrometric elucidation of the mechanisms underlying inhibitionLysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.Group VIA phospholipase A2 mediates enhanced macrophage migration in diabetes mellitus by increasing expression of nicotinamide adenine dinucleotide phosphate oxidase 4.Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.Tumor cell group via phospholipase A₂ is involved in prostate cancer development.Polarization of Macrophages toward M2 Phenotype Is Favored by Reduction in iPLA2β (Group VIA Phospholipase A2)Lipoquality control by phospholipase A2 enzymes.Changes in mRNA/protein expression and signaling pathways in in vivo passaged mouse ovarian cancer cells.
P2860
Q27015257-ACB38422-3485-4824-A40B-F44BC1028E80Q34171442-143E6A36-610F-4EFD-98A1-DC8B45D15D16Q34602974-1209DC21-F9CE-4889-AB97-0D0700A78790Q34782186-0B64BC47-F204-44A4-B466-BAAF6A4CFD88Q35070149-997D4DC7-1B08-470C-81CC-AF547EA9D360Q35423551-127A88E6-1BDA-418B-9732-542D86C2B69FQ35994344-979C5228-90FE-4F06-BD3B-0EDA614C2CF0Q36117436-16EF1176-733D-467F-9D16-6428A6F13B99Q36847992-67CC249A-1B72-44B3-A6C7-2CF7945EE90EQ37027268-6B936778-3192-40E7-BA7B-5EEE385FB8CBQ38101074-D2260EB3-FE7C-4D7A-A00D-83515345EC0EQ38532119-1ACB7874-1E42-4BB6-9D7B-55E2E6D55478Q38812074-F3073DCF-7C43-4A1F-8B73-7EA1C55609D0Q39660426-95EDE916-798B-4D22-BD89-46B1A455E9C4Q42725788-9CD6745D-343C-4ABA-8CEF-BE9A302866EAQ47133692-7F91CE2D-3EC4-408B-B2EB-AD727E4C7954Q55433301-593C5030-56BD-48AF-8ACC-AA2D13CCD79A
P2860
Group VIA phospholipase A2 in both host and tumor cells is involved in ovarian cancer development.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Group VIA phospholipase A2 in ...... in ovarian cancer development.
@ast
Group VIA phospholipase A2 in ...... in ovarian cancer development.
@en
Group VIA phospholipase A2 in ...... in ovarian cancer development.
@nl
type
label
Group VIA phospholipase A2 in ...... in ovarian cancer development.
@ast
Group VIA phospholipase A2 in ...... in ovarian cancer development.
@en
Group VIA phospholipase A2 in ...... in ovarian cancer development.
@nl
prefLabel
Group VIA phospholipase A2 in ...... in ovarian cancer development.
@ast
Group VIA phospholipase A2 in ...... in ovarian cancer development.
@en
Group VIA phospholipase A2 in ...... in ovarian cancer development.
@nl
P2093
P2860
P356
P1433
P1476
Group VIA phospholipase A2 in ...... in ovarian cancer development.
@en
P2093
Dongmei Wang
George Earl Sandusky
Hong Zhang
Zhenwen Zhao
P2860
P304
P356
10.1096/FJ.10-161356
P407
P577
2010-06-08T00:00:00Z